"After Lyco Works asked just a few incisive technical questions, it became clear that we needed to rethink where the technology could be utilized.”

—Pete Canalichio
CEO at Brand Licensing Expert

Protecting your Investment in New Product Development

May 20th, 2019

For military training purposes, this robust Slingshot device includes novel chemical and electronic technologies to create an explosion, flash, and bang to simulate the effects of real grenades.  This grenade, however, is non-lethal despite the impact of the explosive force it creates.

Lyco Works has been working with Slingshot Product Development Group in Lawrenceville GA recently. Here’s how we’ve been helping their clients develop an IP strategy to help patent protect the new products that Slingshot creates for them…

Read the rest of this entry »

The Dutch Tulip Mania of 1637… Learnings for Pre-Investment Technical Diligence

February 14th, 2019

A tulip bulb could cost a king’s ransom in 17th century Holland – but what lessons can today’s technology investors learn from the 1637 bubble?
Read the rest of this entry »

Broadening Patent Protection – with Human Experience Factors

June 9th, 2018

Please join me on June 20th for a live webinar on Broadening Patent Claims:  Lessons from Automotive and Consumer Goods.

11:00am EDT / 4:00pm BST, Wednesday June 20th

The webinar is free, however, registration is required.  You can register by clicking here.   Looking forward to it!

Read the rest of this entry »

Expanded Chemical Searching Capabilities

April 2nd, 2018

  • How similar are your chemical structures to those mentioned in your competitor’s patents?
  • Who’s running clinical trials on compounds similar to you own?  What stage are they at?
  • Which visually similar chemical compounds are discussed in the patent literature?  Which are not?

With an expanded license to powerful software, we are able to answer these questions for you.  We synthesize these data into a customized dashboard, and add business impact for your specific concerns and needs. Read the rest of this entry »

New Patent Monitoring Service

January 4th, 2018

How well are you keeping up with new IP publications pertinent to your business?

Thousands of patent applications and issued patents publish around the world on a weekly basis.  Of the almost 120,000 patents and applications published weekly in 2017:

    • Which ones may have had financial impact to your business? 
    • Which ones threaten your short and long term competitiveness? 
    • Which ones offer opportunities for future expansion and growth?

Lyco Works now provides a monthly digest, highlighting publications of interest and impact to your business.

A new service offering for 2018.   Read the rest of this entry »

Eye Treatment for Dark Circles and Bags

October 2nd, 2017

Technology for License or Sale

Dr. Cynthia Boxrud formulated a pharmaceutical active into a cream and used it in her plastic surgery practice. She found that it significantly reduced the dark discoloration and swelling under the eyes.

Case #1: Before


Case #2: Before


Four products were developed, and sold on the QVC Shopping Channel. The product was successful in the marketplace, however, Dr. Boxrud made the decision to return to her surgical practice full time, and eventually decided to sell the technology.

Read the rest of this entry »

Concept to Commercialization

September 12th, 2017

Learn how successful entrepreneurs transform an idea into a successful product or service.

Lyco Works, in collaboration with Say Consulting LLC, is proud to announce our 1 day symposium workshop: “The Chemical Entrepreneur :  From Concept to Commercialization.”  With guests invited from industry and academia, Terry Say and I will speak at the Southeastern Regional Meeting of the American Chemical Society (SERMACS), in Charlotte NC on November 9th.  Don’t forget to pre-register for the symposium when you register for the SERMACS conference so that we can provide your lunch.  Read the rest of this entry »

Progress Against Cancer – DNA-Personalized Medicine

August 4th, 2017

In one way or another, very few of us are left untouched by this disease.  As many of you know, it’s been almost a year  since I lost my Dad to cancer (along with several friends, I might add) so I was interested to read in Chemical & Engineering News (C&EN Vol. 95 No. 11 July 3rd, 2017) that a new drug has been approved that treats cancers in any tissue –provided that the patient has a specific genetic profile.  The FDA approval of Keytruda® (Merck & Co.)  illuminates a paradigm shift in the approach to cancer research.  Read the rest of this entry »

New Patent Analytical Tools & Services

July 10th, 2017

In efforts directed at advancing our clients’ abilities to patent protect the consumer experiences (along with the configuration of their inventions,) Lyco Works has augmented patent analysis capabilities through acquisition of a license to PatSnap.  Using this premium tool, we can now search over 122,000,000 patent documents from 119 jurisdictions around the world.  The system also searches non-patent literature — particularly useful for chemical patent work, identification of patents litigated for infringement, and known license agreements.

Data can be synthesized and analyzed in numerous different ways, and graphically summarized to provide both detailed as well as executive summary information.  This technology landscape summarizes around 1,200 patent documents assigned to The Procter & Gamble Co. that include visual, color, and tactile sensation claims.  

Patents litigated for infringement are identified with red markers, while known licensed patents are marked in blue. Note the sky-blue “white-space” hiding behind the green patent hill in the foreground… Read the rest of this entry »

Atlanta IP Think Tank Convenes – IP Strategy and Enterprise Growth

June 10th, 2017

Lyco Works and C-Synergies co-chaired the Atlanta IP Think Tank once again this year, hosted by Georgia State University College of Law.  Bringing together around 35 individuals from local larger companies, representatives from Atlanta’s three major schools with technology transfer functions, Emory, GA Tech, and GSU, as well as representatives from the Centers for Disease Control and several sponsoring law firms.  The individuals included senior patent attorneys, as well as business development specialists, dealmakers, and senior R&D leadership.   Read the rest of this entry »